New eBook Update: Clinical Variant Analysis – Second Edition

· Andreas Scherer · About Golden Helix

This morning I released a new version of my eBook “Clinical Variant Analysis – Second Edition.”

The clinical interpretation of variants in Next-Gen Sequencing is a quickly evolving field. While the body of knowledge is growing exponentially, experts have to derive sound, clinical decisions leveraging an ever-expanding set of specialty databases, clinical publications, and algorithms that are designed to predict the impact of specific variants in the resulting protein.

The specific steps and considerations that need to be considered are defined by the American College of Medical Genetics and Genomics. The guidelines for the interpretation of sequenced variants were published in 2015 with an addendum for loss of function variants added in 2018. A second set of guidelines for interpreting Copy Number Variants (CNVs) was published in 2020. In this eBook, I have summarized the key concepts of these guidelines. I cover what defines a pathogenic and benign variant respectively, and everything in between. I go over scoring mechanisms that allow us to classify a variant clinically. Lastly, I discuss a few interesting cases of variants and their classifications.

To receive a complimentary copy, please visit the following link: https://www.goldenhelix.com/resources/ebooks/clinical-variant-analysis.html. I hope you and your loved ones are in good health.

Why This eBook Matters

Whether you are a seasoned clinical geneticist, a researcher new to variant interpretation, or a lab professional looking to refine your understanding, this eBook serves as a practical guide to navigating the evolving landscape of genomic interpretation. With clear, structured explanations and real-world examples, Clinical Variant Analysis – Second Edition distills complex guidelines into actionable insights.

As clinical genomics continues to advance, having a firm grasp of variant classification frameworks is essential for ensuring accurate diagnoses and confident decision-making. We’re proud to support professionals around the world in this effort and hope this eBook becomes a valuable resource in your toolkit.

We invite you to explore the new edition and share it with colleagues who may benefit. At Golden Helix, we remain committed to equipping the scientific and clinical community with tools, knowledge, and support to advance precision medicine.


Thank you for being part of this important work.

Leave a comment

Andreas Scherer

About Andreas Scherer

Dr. Andreas Scherer is CEO of Golden Helix. The company has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over a decade. Its innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from next-generation sequencing. With its solutions, hundreds of the world’s hospitals and testing labs are able to harness the full potential of genomics to identify the cause of disease, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in thousands of peer-reviewed publications. Golden Helix is also on the Inc 5000 list of the fastest-growing private companies in the US. He is also Managing Partner of Salto Partners, Inc, a management consulting firm headquartered in Nevada.  He has extensive experience successfully managing growth as well as orchestrating complex turnaround situations. His company, Salto Partners, advises on business strategy, financing, sales, and operations. Clients are operating in the high-tech and life sciences space. Dr. Scherer holds a Ph.D. in computer science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co- author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone”, is a prizewinner in the 2012 Eric Hoffer Book Awards competition, and has been named a finalist in the 2012 Next Generation Indie Book Awards! 

View all posts by Andreas Scherer →